{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T04:49:41Z","timestamp":1783745381405,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012940","name":"Universit\u00e4tsklinikum T\u00fcbingen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012940","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Hepatitis B virus (HBV) genotype distribution, resistance mutations, and hepatitis delta virus (HDV) co-infection play critical roles in disease progression and treatment outcomes yet remain understudied in central Vietnam. This study aimed to understand their characteristics and association with clinical outcomes. Serum from 376 HBV-infected patients in Hue, Vietnam (June 2023-June 2024) was analysed. HBV-DNA and HDV-RNA were extracted and amplified by nested PCR, followed by Sanger sequencing. HBV viral load was quantified using real-time PCR. HBV and HDV genotypes were determined through phylogenetic analysis, and HBV resistance mutation identified using geno2pheno [hbv]. HBV genotype B was predominant (95%), followed by genotypes C (5%) and D (0.3%). Infection with genotype C was significantly associated with an increased risk of hepatocellular carcinoma (OR\u2009=\u20096.05, 95% CI: 1.6\u201322.5;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.007). Classical drug resistance mutations were rare (1.3%), while non-classical mutations were observed in 33% of sequences, especially V207M in genotype B. HDV co-infection was identified in two patients (0.5%), both infected with HDV genotype 1 and associated with elevated liver enzymes and liver disease progression. In conclusion, HBV genotype C emerged as a key predictor of hepatocellular carcinoma risk in Central Vietnam, highlighting the need of genotype-based monitoring. Low antiviral resistance and HDV co-infection likely reflect effective vaccination and treatment in the region. Routine HDV screening and resistance surveillance are recommended.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-31423-1","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T04:19:01Z","timestamp":1765340341000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Genomic surveillance of HBV and HDV reveals genotype-specific risk of liver disease in central Vietnam"],"prefix":"10.1038","volume":"15","author":[{"given":"Le Chi","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran Thi Tien","family":"Xinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dang Ngoc","family":"Phuoc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Thi","family":"Dung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran Thi Kim","family":"Loan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pham","family":"Van Duc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dao Thi","family":"Huyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le Thi Kieu","family":"Linh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le Huu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thirumalaisamy P.","family":"Velavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"31423_CR1","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 83, 502\u2013583 (2025)."},{"key":"31423_CR2","first-page":"100468","volume":"24","author":"B Flower","year":"2022","unstructured":"Flower, B. et al. Seroprevalence of hepatitis B, C and D in vietnam: A systematic review and meta-analysis. Lancet Reg. Health West. Pac. 24, 100468 (2022).","journal-title":"Lancet Reg. Health West. Pac."},{"key":"31423_CR3","doi-asserted-by":"publisher","first-page":"116","DOI":"10.4254\/wjh.v10.i1.116","volume":"10","author":"SH Nguyen-Dinh","year":"2018","unstructured":"Nguyen-Dinh, S. H. et al. High burden of hepatocellular carcinoma and viral hepatitis in Southern and central vietnam: experience of a large tertiary referral center, 2010 to 2016. World J. Hepatol. 10, 116\u2013123 (2018).","journal-title":"World J. Hepatol."},{"key":"31423_CR4","doi-asserted-by":"crossref","unstructured":"Bello, K. E. et al. A Recent Prevalence of Hepatitis B Virus (HBV) Genotypes and Subtypes in Asia: A Systematic Review and Meta-Analysis. Healthcare (Basel) 11, 1011 (2023).","DOI":"10.3390\/healthcare11071011"},{"key":"31423_CR5","doi-asserted-by":"crossref","unstructured":"Hoan, N. X. et al. Predominance of HBV Genotype B and HDV Genotype 1 in Vietnamese Patients with Chronic Hepatitis. Viruses 13, 346 (2021).","DOI":"10.3390\/v13020346"},{"key":"31423_CR6","first-page":"204993612513447","volume":"12","author":"MC Hoang","year":"2025","unstructured":"Hoang, M. C. et al. Hepatitis B virus genotypes and antiviral drug resistance mutations in treatment-naive patients with chronic hepatitis B in Bacninh, vietnam: a cross-sectional study. Ther. Adv. Infect. Dis. 12, 20499361251344784 (2025).","journal-title":"Ther. Adv. Infect. Dis."},{"key":"31423_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jgar.2023.02.013","volume":"33","author":"TK Nguyen","year":"2023","unstructured":"Nguyen, T. K. & Van Le, D. Resistant mutations within the hepatitis B virus reverse transcriptase sequence in treatment failure patients with chronic HBV infection in Vietnam. J. Glob Antimicrob. Resist. 33, 35\u201341 (2023).","journal-title":"J. Glob Antimicrob. Resist."},{"key":"31423_CR8","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1093\/infdis\/jiz633","volume":"221","author":"Z Miao","year":"2020","unstructured":"Miao, Z. et al. Estimating the global Prevalence, disease Progression, and clinical outcome of hepatitis delta virus infection. J. Infect. Dis. 221, 1677\u20131687 (2020).","journal-title":"J. Infect. Dis."},{"key":"31423_CR9","doi-asserted-by":"publisher","first-page":"8047","DOI":"10.1038\/s41598-018-26446-w","volume":"8","author":"MT Binh","year":"2018","unstructured":"Binh, M. T. et al. HDV infection rates in Northern Vietnam. Sci. Rep. 8, 8047 (2018).","journal-title":"Sci. Rep."},{"key":"31423_CR10","doi-asserted-by":"publisher","first-page":"e0175304","DOI":"10.1371\/journal.pone.0175304","volume":"12","author":"HM Nguyen","year":"2017","unstructured":"Nguyen, H. M. et al. Prevalence and genotype distribution of hepatitis delta virus among chronic hepatitis B carriers in central Vietnam. PLoS One. 12, e0175304 (2017).","journal-title":"PLoS One"},{"key":"31423_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1055\/s-0033-1345716","volume":"33","author":"CJ Liu","year":"2013","unstructured":"Liu, C. J. & Kao, J. H. Global perspective on the natural history of chronic hepatitis B: role of hepatitis B virus genotypes A to J. Semin Liver Dis. 33, 97\u2013102 (2013).","journal-title":"Semin Liver Dis."},{"issue":"Suppl 1","key":"31423_CR12","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/S1386-6532(06)80003-X","volume":"36","author":"JP Allain","year":"2006","unstructured":"Allain, J. P. Epidemiology of hepatitis B virus and genotype. J. Clin. Virol. 36 (Suppl 1), S12\u201317 (2006).","journal-title":"J. Clin. Virol."},{"key":"31423_CR13","doi-asserted-by":"crossref","unstructured":"Phan, N. M. H., Faddy, H., Flower, R., Spann, K. & Roulis, E. In silico Analysis of Genetic Diversity of Human Hepatitis B Virus in Southeast Asia, Australia and New Zealand. Viruses, 12 (2020).","DOI":"10.3390\/v12040427"},{"key":"31423_CR14","doi-asserted-by":"publisher","first-page":"5657","DOI":"10.1128\/JVI.02556-07","volume":"82","author":"TT Tran","year":"2008","unstructured":"Tran, T. T., Trinh, T. N. & Abe, K. New complex Recombinant genotype of hepatitis B virus identified in Vietnam. J. Virol. 82, 5657\u20135663 (2008).","journal-title":"J. Virol."},{"key":"31423_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/hepr.12350","volume":"45","author":"SH Do","year":"2015","unstructured":"Do, S. H. et al. High prevalences of hepatitis B and C virus infections among adults living in Binh Thuan province, Vietnam. Hepatol. Res. 45, 259\u2013268 (2015).","journal-title":"Hepatol. Res."},{"key":"31423_CR16","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1136\/gut.2003.033324","volume":"53","author":"HL Chan","year":"2004","unstructured":"Chan, H. L. et al. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma. Gut 53, 1494\u20131498 (2004).","journal-title":"Gut"},{"key":"31423_CR17","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s12072-008-9112-z","volume":"3","author":"BJ McMahon","year":"2009","unstructured":"McMahon, B. J. The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B. Hepatol. Int. 3, 334\u2013342 (2009).","journal-title":"Hepatol. Int."},{"key":"31423_CR18","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.jhep.2017.06.019","volume":"67","author":"TC Yip","year":"2017","unstructured":"Yip, T. C. et al. Impact of age and gender on risk of hepatocellular carcinoma after hepatitis B surface antigen seroclearance. J. Hepatol. 67, 902\u2013908 (2017).","journal-title":"J. Hepatol."},{"key":"31423_CR19","doi-asserted-by":"crossref","unstructured":"Trang, N. H. et al. A17 Molecular characteristics of hepatitis B virus (HBV) isolated from chronic hepatitis B patients in South Vietnam. Virus Evol 3, vew036.016 (2017).","DOI":"10.1093\/ve\/vew036.016"},{"key":"31423_CR20","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.3748\/wjg.v24.i16.1708","volume":"24","author":"YM Choi","year":"2018","unstructured":"Choi, Y. M., Lee, S. Y. & Kim, B. J. Naturally occurring hepatitis B virus reverse transcriptase mutations related to potential antiviral drug resistance and liver disease progression. World J. Gastroenterol. 24, 1708\u20131724 (2018).","journal-title":"World J. Gastroenterol."},{"key":"31423_CR21","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1086\/598951","volume":"199","author":"C Noguchi","year":"2009","unstructured":"Noguchi, C. et al. G-to-A hypermutation in hepatitis B virus (HBV) and clinical course of patients with chronic HBV infection. J. Infect. Dis. 199, 1599\u20131607 (2009).","journal-title":"J. Infect. Dis."},{"key":"31423_CR22","doi-asserted-by":"publisher","first-page":"135965352513490","DOI":"10.1177\/13596535251349054","volume":"30","author":"TD Thuy","year":"2025","unstructured":"Thuy, T. D., Ha, N. T., Cuong, D. D., Long, L. V. & Anh, N. Q. Cost-effectiveness of Tenofovir Alafenamide fumarate for treatment of chronic hepatitis B: evidence from a tertiary hospital in Vietnam. Antivir Ther. 30, 13596535251349054 (2025).","journal-title":"Antivir Ther."},{"key":"31423_CR23","first-page":"202","volume":"2","author":"N Gupta","year":"2014","unstructured":"Gupta, N., Goyal, M., Wu, C. H. & Wu, G. Y. The molecular and structural basis of HBV-resistance to Nucleos(t)ide analogs. J. Clin. Transl Hepatol. 2, 202\u2013211 (2014).","journal-title":"J. Clin. Transl Hepatol."},{"key":"31423_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11262-017-1518-z","volume":"54","author":"HY Zhang","year":"2018","unstructured":"Zhang, H. Y. et al. Evolution of drug-resistant mutations in HBV genomes in patients with treatment failure during the past seven years (2010\u20132016). Virus Genes. 54, 41\u201347 (2018).","journal-title":"Virus Genes"},{"key":"31423_CR25","doi-asserted-by":"publisher","first-page":"e78094","DOI":"10.1371\/journal.pone.0078094","volume":"8","author":"BT Sy","year":"2013","unstructured":"Sy, B. T. et al. High prevalence and significance of hepatitis D virus infection among treatment-naive HBsAg-positive patients in Northern Vietnam. PLoS One. 8, e78094 (2013).","journal-title":"PLoS One"},{"key":"31423_CR26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.vaccine.2013.11.004","volume":"32","author":"TH Nguyen","year":"2014","unstructured":"Nguyen, T. H. et al. A reduction in chronic hepatitis B virus infection prevalence among children in Vietnam demonstrates the importance of vaccination. Vaccine 32, 217\u2013222 (2014).","journal-title":"Vaccine"},{"key":"31423_CR27","doi-asserted-by":"publisher","first-page":"e110143","DOI":"10.1371\/journal.pone.0110143","volume":"9","author":"A Goyal","year":"2014","unstructured":"Goyal, A. & Murray, J. M. The impact of vaccination and antiviral therapy on hepatitis B and hepatitis D epidemiology. PLoS One. 9, e110143 (2014).","journal-title":"PLoS One"},{"key":"31423_CR28","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1093\/bib\/bbx108","volume":"20","author":"K Katoh","year":"2019","unstructured":"Katoh, K., Rozewicki, J. & Yamada, K. D. MAFFT online service: multiple sequence alignment, interactive sequence choice and visualization. Brief. Bioinform. 20, 1160\u20131166 (2019).","journal-title":"Brief. Bioinform"},{"key":"31423_CR29","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1093\/molbev\/msab120","volume":"38","author":"K Tamura","year":"2021","unstructured":"Tamura, K., Stecher, G. & Kumar, S. MEGA11: molecular evolutionary genetics analysis version 11. Mol. Biol. Evol. 38, 3022\u20133027 (2021).","journal-title":"Mol. Biol. Evol."},{"key":"31423_CR30","doi-asserted-by":"publisher","first-page":"W293","DOI":"10.1093\/nar\/gkab301","volume":"49","author":"I Letunic","year":"2021","unstructured":"Letunic, I. & Bork, P. Interactive tree of life (iTOL) v5: an online tool for phylogenetic tree display and annotation. Nucleic Acids Res. 49, W293\u2013W296 (2021).","journal-title":"Nucleic Acids Res."},{"key":"31423_CR31","doi-asserted-by":"publisher","first-page":"e6712","DOI":"10.5812\/hepatmon.6712","volume":"13","author":"M Mahabadi","year":"2013","unstructured":"Mahabadi, M. et al. Drug-related mutational patterns in hepatitis B virus (HBV) reverse transcriptase proteins from Iranian treatment-naive chronic HBV patients. Hepat. Mon. 13, e6712 (2013).","journal-title":"Hepat. Mon"},{"key":"31423_CR32","doi-asserted-by":"publisher","first-page":"8078","DOI":"10.1038\/s41598-019-44604-6","volume":"9","author":"X Zhang","year":"2019","unstructured":"Zhang, X. et al. Potential resistant mutations within HBV reverse transcriptase sequences in nucleos(t)ide analogues-experienced patients with hepatitis B virus infection. Sci. Rep. 9, 8078 (2019).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31423-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31423-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31423-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T09:37:35Z","timestamp":1765359455000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31423-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["31423"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-31423-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"20 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43491"}}